602 related articles for article (PubMed ID: 23913459)
1. Lead dependent tricuspid dysfunction: Analysis of the mechanism and management in patients referred for transvenous lead extraction.
Polewczyk A; Kutarski A; Tomaszewski A; Brzozowski W; Czajkowski M; Polewczyk M; Janion M
Cardiol J; 2013; 20(4):402-10. PubMed ID: 23913459
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.
Nazmul MN; Cha YM; Lin G; Asirvatham SJ; Powell BD
Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162
[TBL] [Abstract][Full Text] [Related]
3. When should a mechanical tricuspid valve replacement be considered?
Said SM; Burkhart HM; Schaff HV; Johnson JN; Connolly HM; Dearani JA
J Thorac Cardiovasc Surg; 2014 Aug; 148(2):603-8. PubMed ID: 24199756
[TBL] [Abstract][Full Text] [Related]
4. The impact of transvenous lead extraction on tricuspid valve function.
Coffey JO; Sager SJ; Gangireddy S; Levine A; Viles-Gonzalez JF; Fischer A
Pacing Clin Electrophysiol; 2014 Jan; 37(1):19-24. PubMed ID: 23991637
[TBL] [Abstract][Full Text] [Related]
5. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
Lin G; Nishimura RA; Connolly HM; Dearani JA; Sundt TM; Hayes DL
J Am Coll Cardiol; 2005 May; 45(10):1672-5. PubMed ID: 15893186
[TBL] [Abstract][Full Text] [Related]
6. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation.
Mediratta A; Addetia K; Yamat M; Moss JD; Nayak HM; Burke MC; Weinert L; Maffessanti F; Jeevanandam V; Mor-Avi V; Lang RM
JACC Cardiovasc Imaging; 2014 Apr; 7(4):337-47. PubMed ID: 24631508
[TBL] [Abstract][Full Text] [Related]
7. Tricuspid valve repair for severe tricuspid regurgitation due to pacemaker leads.
Uehara K; Minakata K; Watanabe K; Sakaguchi H; Yamazaki K; Ikeda T; Sakata R
Asian Cardiovasc Thorac Ann; 2016 Jul; 24(6):541-5. PubMed ID: 27286784
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of tricuspid regurgitation after lead extraction.
Shanafelt C; Middour TG; Ibrahim R; Leal M; Lloyd MS; Shah AD; Westerman SB; El-Chami MF; Merchant FM; Bhatia NK;
J Cardiovasc Electrophysiol; 2024 May; 35(5):929-938. PubMed ID: 38450808
[TBL] [Abstract][Full Text] [Related]
9. Permanent cardiac pacing and its influence on tricuspid valve function.
Krupa W; Kozłowski D; Derejko P; Swiatecka G
Folia Morphol (Warsz); 2001 Nov; 60(4):249-57. PubMed ID: 11770335
[TBL] [Abstract][Full Text] [Related]
10. [Long-term effects of permanent pacemaker implantation on tricuspid valve regurgitation].
Ren CL; Wang Y; Wang R; Li BJ; Geng RY; Gao CQ
Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(30):2118-22. PubMed ID: 23158275
[TBL] [Abstract][Full Text] [Related]
11. Utility of concomitant tricuspid valve procedures for patients undergoing implantation of a continuous-flow left ventricular device.
Piacentino V; Ganapathi AM; Stafford-Smith M; Hsieh MK; Patel CB; Simeone AA; Rogers JG; Milano CA
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1217-21. PubMed ID: 22938779
[TBL] [Abstract][Full Text] [Related]
12. Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation.
Park SJ; Gentry JL; Varma N; Wazni O; Tarakji KG; Mehta A; Mick S; Grimm R; Wilkoff BL
JACC Clin Electrophysiol; 2018 Nov; 4(11):1421-1428. PubMed ID: 30466846
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of three-dimensional echocardiography in the evaluation of tricuspid regurgitation induced by implantable device leads.
Cheng Y; Gao H; Tang L; Li J; Yao L
Echocardiography; 2016 Nov; 33(11):1689-1696. PubMed ID: 27539645
[TBL] [Abstract][Full Text] [Related]
14. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
Höke U; Auger D; Thijssen J; Wolterbeek R; van der Velde ET; Holman ER; Schalij MJ; Bax JJ; Delgado V; Marsan NA
Heart; 2014 Jun; 100(12):960-8. PubMed ID: 24449717
[TBL] [Abstract][Full Text] [Related]
15. Tricuspid valve damage and improvement following transvenous lead extraction procedures.
Polewczyk A; Jacheć W; Nowosielecka D; Kutarski A
J Cardiovasc Electrophysiol; 2024 May; 35(5):939-941. PubMed ID: 38515000
[No Abstract] [Full Text] [Related]
16. Tricuspid Valve Damage Related to Transvenous Lead Extraction.
Polewczyk A; Jacheć W; Nowosielecka D; Tomaszewski A; Brzozowski W; Szczęśniak-Stańczyk D; Duda K; Kutarski A
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231579
[TBL] [Abstract][Full Text] [Related]
17. Role of tricuspid valve repair for moderate tricuspid regurgitation during minimally invasive mitral valve surgery.
Pfannmueller B; Verevkin A; Borger MA; Mende M; Davierwala P; Garbade J; Mohr FW; Misfeld M
Thorac Cardiovasc Surg; 2013 Aug; 61(5):386-91. PubMed ID: 23475798
[TBL] [Abstract][Full Text] [Related]
18. Severe tricuspid valve regurgitation due to perforation by permanent pacemaker lead.
Wen-Zong L; Liang M
J Card Surg; 2011 Sep; 26(5):555-6. PubMed ID: 21810118
[TBL] [Abstract][Full Text] [Related]
19. Impact of Leadless Pacemaker Therapy on Cardiac and Atrioventricular Valve Function Through 12 Months of Follow-Up.
Beurskens NEG; Tjong FVY; de Bruin-Bon RHA; Dasselaar KJ; Kuijt WJ; Wilde AAM; Knops RE
Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007124. PubMed ID: 31060371
[TBL] [Abstract][Full Text] [Related]
20. Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation.
Chang JD; Manning WJ; Ebrille E; Zimetbaum PJ
J Am Coll Cardiol; 2017 May; 69(18):2331-2341. PubMed ID: 28473139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
